In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method
Dei Cas, Michele, Rizzo, Jessica, Scavone, Mariangela, Femia, Eti, Podda, Gian Marco, Bossi, Elena, Bignotto, Monica, Caberlon, Sabrina, Cattaneo, Marco, Paroni, Rita
Published in Scientific reports (14.05.2021)
Published in Scientific reports (14.05.2021)
Get full text
Journal Article
Evaluation of platelet function in essential thrombocythemia under different analytical conditions
Lussana, Federico, Femia, Eti Alessandra, Pugliano, Mariateresa, Podda, Gianmarco, Razzari, Cristina, Maugeri, Norma, Lecchi, Anna, Caberlon, Sabrina, Gerli, Giancarla, Cattaneo, Marco
Published in Platelets (Edinburgh) (17.02.2020)
Published in Platelets (Edinburgh) (17.02.2020)
Get full text
Journal Article
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
Vannucchi, Alessandro M., Antonioli, Elisabetta, Guglielmelli, Paola, Rambaldi, Alessandro, Barosi, Giovanni, Marchioli, Roberto, Marfisi, Rosa Maria, Finazzi, Guido, Guerini, Vittoria, Fabris, Fabrizio, Randi, Maria Luigia, De Stefano, Valerio, Caberlon, Sabrina, Tafuri, Agostino, Ruggeri, Marco, Specchia, Giorgina, Liso, Vincenzo, Rossi, Edoardo, Pogliani, Enrico, Gugliotta, Luigi, Bosi, Alberto, Barbui, Tiziano
Published in Blood (01.08.2007)
Published in Blood (01.08.2007)
Get full text
Journal Article
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
Maffioli, Margherita, Mora, Barbara, Ball, Somedeb, Iurlo, Alessandra, Elli, Elena Maria, Finazzi, Maria Chiara, Polverelli, Nicola, Rumi, Elisa, Caramella, Marianna, Carraro, Maria Cristina, D'Adda, Mariella, Molteni, Alfredo, Sissa, Cinzia, Lunghi, Francesca, Vismara, Alessandro, Ubezio, Marta, Guidetti, Anna, Caberlon, Sabrina, Anghilieri, Michela, Komrokji, Rami, Cattaneo, Daniele, Della Porta, Matteo Giovanni, Giorgino, Toni, Bertù, Lorenza, Brociner, Marco, Kuykendall, Andrew, Passamonti, Francesco
Published in Blood advances (22.03.2022)
Published in Blood advances (22.03.2022)
Get full text
Journal Article
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
Lussana, Federico, Caberlon, Sabrina, Pagani, Chiara, Kamphuisen, Pieter W, Büller, Harry R, Cattaneo, Marco
Published in Thrombosis research (01.09.2009)
Published in Thrombosis research (01.09.2009)
Get full text
Journal Article
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis
Vener, Claudia, Fracchiolla, Nicola Stefano, Gianelli, Umberto, Calori, Rossella, Radaelli, Franca, Iurlo, Alessandra, Caberlon, Sabrina, Gerli, Giancarla, Boiocchi, Leonardo, Deliliers, Giorgio Lambertenghi
Published in Blood (15.02.2008)
Published in Blood (15.02.2008)
Get full text
Journal Article
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia
Passamonti, F, Malabarba, L, Orlandi, E, Barate, C, Canevari, A, Brusamolino, E, Bonfichi, M, Arcaini, L, Caberlon, S, Pascutto, C, Lazzarino, M
Published in Haematologica (Roma) (01.01.2003)
Get full text
Published in Haematologica (Roma) (01.01.2003)
Journal Article
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Commentary
PRCHAL, Josef T, VANNUCCHI, Alessandro M, FABRIS, Fabrizio, LUIGIA RANDI, Maria, DE STEFANO, Valerio, CABERLON, Sabrina, TAFURI, Agostino, RUGGERI, Marco, SPECCHIA, Giorgina, LISO, Vincenzo, ROSSI, Edoardo, POGLIANI, Enrico, ANTONIOLI, Elisabetta, GUGLIOTTA, Luigi, BOSI, Alberto, BARBUI, Tiziano, GUGLIELMELLI, Paola, RAMBALDI, Alessandro, BAROSI, Giovanni, MARCHIOLI, Roberto, MARFISI, Rosa Maria, FINAZZI, Guido, GUERINI, Vittoria
Published in Blood (2007)
Get full text
Published in Blood (2007)
Journal Article
A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma
Corso, A, Arcaini, L, Caberlon, S, Zappasodi, P, Mangiacavalli, S, Lorenzi, A, Rusconi, C, Troletti, D, Maiocchi, MA, Pascutto, C, Morra, E, Lazzarino, M
Published in Haematologica (Roma) (01.10.2002)
Get full text
Published in Haematologica (Roma) (01.10.2002)
Journal Article